Celero is the first U.S. FDA-cleared vacuum-assisted core biopsy device for the breast ultrasound market. The company has also received CE Mark approval for the CeleroMark

«« New MRI Technique Detects Cancerous Breast Tumours


Unilabs Acquires EuradConsult »»


Latest Articles

Celero is the first U.S. FDA-cleared vacuum-assisted core biopsy device for the breast ultrasound market. The company has also received CE Mark approval...